ATHM vs. MEDP, RTO, ULS, STN, CART, BILI, HQY, FOUR, LIF, and LYFT
Should you be buying Autohome stock or one of its competitors? The main competitors of Autohome include Medpace (MEDP), Rentokil Initial (RTO), UL Solutions (ULS), Stantec (STN), Maplebear (CART), Bilibili (BILI), HealthEquity (HQY), Shift4 Payments (FOUR), Life360 (LIF), and Lyft (LYFT). These companies are all part of the "business services" industry.
Autohome vs. Its Competitors
Medpace (NASDAQ:MEDP) and Autohome (NYSE:ATHM) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.
78.0% of Medpace shares are held by institutional investors. Comparatively, 63.1% of Autohome shares are held by institutional investors. 20.3% of Medpace shares are held by insiders. Comparatively, 5.7% of Autohome shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Medpace presently has a consensus price target of $422.27, suggesting a potential downside of 13.93%. Autohome has a consensus price target of $36.00, suggesting a potential upside of 22.28%. Given Autohome's stronger consensus rating and higher probable upside, analysts plainly believe Autohome is more favorable than Medpace.
Medpace has higher earnings, but lower revenue than Autohome. Autohome is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.
Medpace has a beta of 1.44, indicating that its stock price is 44% more volatile than the S&P 500. Comparatively, Autohome has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500.
Autohome has a net margin of 21.74% compared to Medpace's net margin of 18.74%. Medpace's return on equity of 67.66% beat Autohome's return on equity.
In the previous week, Medpace had 18 more articles in the media than Autohome. MarketBeat recorded 21 mentions for Medpace and 3 mentions for Autohome. Autohome's average media sentiment score of 1.75 beat Medpace's score of 1.19 indicating that Autohome is being referred to more favorably in the news media.
Summary
Medpace beats Autohome on 11 of the 17 factors compared between the two stocks.
Get Autohome News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATHM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ATHM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Autohome Competitors List
Related Companies and Tools
This page (NYSE:ATHM) was last updated on 9/13/2025 by MarketBeat.com Staff
